46 related articles for article (PubMed ID: 1306127)
1. Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of lung cancer.
Kiyohara C; Shirakawa T; Hopkin JM
Environ Health Prev Med; 2002 May; 7(2):47-59. PubMed ID: 21432264
[TBL] [Abstract][Full Text] [Related]
2. Modulating influence of cytochrome P-450 MspI polymorphism on serum liver function profiles in coke oven workers.
Wu MT; Ho CK; Huang SL; Yeh YF; Liu CL; Mao IF; Christiani DC
Occup Environ Med; 1999 Mar; 56(3):159-63. PubMed ID: 10448323
[TBL] [Abstract][Full Text] [Related]
3. Interaction between dose and susceptibility to environmental cancer: a short review.
Hietanen E; Husgafvel-Pursiainen K; Vainio H
Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):749-54. PubMed ID: 9255556
[TBL] [Abstract][Full Text] [Related]
4. The role of individual susceptibility in cancer burden related to environmental exposure.
Bartsch H; Hietanen E
Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):569-77. PubMed ID: 8781385
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in the human CYP1A1 gene as susceptibility factors for lung cancer: exon-7 mutation (4889 A to G), and a T to C mutation in the 3'-flanking region.
Drakoulis N; Cascorbi I; Brockmöller J; Gross CR; Roots I
Clin Investig; 1994 Feb; 72(3):240-8. PubMed ID: 7912124
[TBL] [Abstract][Full Text] [Related]
6. CYP2D6 genotype determination in the Danish population.
Brøsen K; Nielsen PN; Brusgaard K; Gram LF; Skjødt K
Eur J Clin Pharmacol; 1994; 47(3):221-5. PubMed ID: 7867674
[TBL] [Abstract][Full Text] [Related]
7. Tobacco and cancer: epidemiology and the laboratory.
Vineis P; Caporaso N
Environ Health Perspect; 1995 Feb; 103(2):156-60. PubMed ID: 7737063
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphism of cytochromes P450: interethnic differences and relationship to incidence of lung cancer.
Ingelman-Sundberg M; Johansson I; Persson I; Yue QY; Dahl ML; Bertilsson L; Sjöqvist F
Pharmacogenetics; 1992 Dec; 2(6):264-71. PubMed ID: 1306127
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphism of cytochromes P450 1A1, 2D6 and 2E1: regulation and toxicological significance.
Rannug A; Alexandrie AK; Persson I; Ingelman-Sundberg M
J Occup Environ Med; 1995 Jan; 37(1):25-36. PubMed ID: 7620940
[TBL] [Abstract][Full Text] [Related]
10. Metabolic cytochrome P450 genotypes and assessment of individual susceptibility to lung cancer.
Hirvonen A; Husgafvel-Pursiainen K; Anttila S; Karjalainen A; Sorsa M; Vainio H
Pharmacogenetics; 1992 Dec; 2(6):259-63. PubMed ID: 1306126
[TBL] [Abstract][Full Text] [Related]
11. Genetic factors in individual responses to environmental exposures.
Hirvonen A
J Occup Environ Med; 1995 Jan; 37(1):37-43. PubMed ID: 7620941
[TBL] [Abstract][Full Text] [Related]
12. Debrisoquin oxidation genotype and susceptibility to lung cancer.
Agúndez JA; Martínez C; Ladero JM; Ledesma MC; Ramos JM; Martín R; Rodriguez A; Jara C; Benítez J
Clin Pharmacol Ther; 1994 Jan; 55(1):10-4. PubMed ID: 8299311
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetic analysis of the cytochrome P450-debrisoquine hydroxylase locus and association with cancer susceptibility.
Smith CA; Moss JE; Gough AC; Spurr NK; Wolf CR
Environ Health Perspect; 1992 Nov; 98():107-12. PubMed ID: 1486838
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
